Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CART Therapy”

129 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 129 results

Early research (Phase 1)Looking for participantsNCT06875063
What this trial is testing

GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL

Who this might be right for
Non-hodgkin LymphomaRefractory LymphomaChimeric Antigen Receptor T-cell
The First Affiliated Hospital of Xiamen University 45
Very early researchNot Yet RecruitingNCT07234721
What this trial is testing

SL4903 CAR-T Therapy for Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma (RRMM)
Institute of Hematology & Blood Diseases Hospital, China 9
Early research (Phase 1)Active Not RecruitingNCT03635632
What this trial is testing

C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)

Who this might be right for
Relapsed NeuroblastomaRefractory NeuroblastomaRelapsed Osteosarcoma+4 more
Baylor College of Medicine 94
Very early researchLooking for participantsNCT06586658
What this trial is testing

Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells

Who this might be right for
Renal Cell Carcinoma
Shanghai Changzheng Hospital 9
Early research (Phase 1)Looking for participantsNCT06209619
What this trial is testing

CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma

Who this might be right for
B-Cell Non-Hodgkin Lymphoma-RecurrentDiffuse Large B-Cell Lymphoma-RecurrentFollicular Lymphoma-Recurrent+9 more
Nathan Denlinger 18
Early research (Phase 1)Looking for participantsNCT07106749
What this trial is testing

CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaB Acute Lymphoblastic Leukemia/Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 12
Testing effectiveness (Phase 2)UnknownNCT03633773
What this trial is testing

Safety and Efficacy Evaluation of MUC-1 CART in the Treatment of Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University 9
Testing effectiveness (Phase 2)Looking for participantsNCT06066346
What this trial is testing

Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 17
Not applicableLooking for participantsNCT07219303
What this trial is testing

Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Fox Chase Cancer Center 80
Not applicableLooking for participantsNCT06333275
What this trial is testing

Restoration of Immunity to Vaccine Preventable Diseases After CART-T Cell Therapy

Who this might be right for
Vaccine Immunity in CAR-T Cell Therapy Recipients
Insel Gruppe AG, University Hospital Bern 80
Testing effectiveness (Phase 2)UnknownNCT04637503
What this trial is testing

4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma

Who this might be right for
Neuroblastoma
Shenzhen Geno-Immune Medical Institute 100
Not applicableUnknownNCT05308875
What this trial is testing

Efficacy and Safety Evaluation of PD1-BCMA-CART

Who this might be right for
Multiple Myeloma
Bioray Laboratories 9
Not applicableEnded earlyNCT03473496
What this trial is testing

CAR-T Cells Therapy in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma(MM)
Zhujiang Hospital 2
Early research (Phase 1)Ended earlyNCT05352542
What this trial is testing

GPC3-targeting CART Cell in Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
jianming xu 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT06084884
What this trial is testing

A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
AstraZeneca 94
Early research (Phase 1)Looking for participantsNCT06201416
What this trial is testing

Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Sonoma Biotherapeutics, Inc. 24
Not applicableStudy completedNCT01295034
What this trial is testing

Vitamin D Supplements for HIV-positive Patients on cART

Who this might be right for
HIV-associated Co-morbidities
Andrea Branch 62
Early research (Phase 1)Looking for participantsNCT07109518
What this trial is testing

UCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia (AML)T Lymphoblastic Leukemia/Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 12
Not applicableNot Yet RecruitingNCT07008872
What this trial is testing

CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia

Who this might be right for
CD7+ LymphomaCD7+ Acute Leukemia
Qi deng 40
Not applicableStudy completedNCT03600103
What this trial is testing

Technology Based Community Health Nursing to Improve Combination Anti-Retroviral Therapy (cART) Adherence and Virologic Suppression in Youth Living With HIV

Who this might be right for
HIV InfectionsAdherence, Medication
Johns Hopkins University 76
Load More Results